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Abstract
Conflict and war have long been recognized as determinants of infectious disease risk. Re-
emergence of epidemic sleeping sickness in sub-Saharan Africa since the 1970s has coincided with
extensive civil conflict in affected regions. Sleeping sickness incidence has placed increasing pressure
on the health resources of countries already burdened by malaria, HIV/AIDS, and tuberculosis. In
areas of Sudan, the Democratic Republic of the Congo, and Angola, sleeping sickness occurs in
epidemic proportions, and is the first or second greatest cause of mortality in some areas, ahead
of HIV/AIDS. In Uganda, there is evidence of increasing spread and establishment of new foci in
central districts. Conflict is an important determinant of sleeping sickness outbreaks, and has
contributed to disease resurgence. This paper presents a review and characterization of the
processes by which conflict has contributed to the occurrence of sleeping sickness in Africa.
Conflict contributes to disease risk by affecting the transmission potential of sleeping sickness via
economic impacts, degradation of health systems and services, internal displacement of
populations, regional insecurity, and reduced access for humanitarian support. Particular focus is
given to the case of sleeping sickness in south-eastern Uganda, where incidence increase is
expected to continue. Disease intervention is constrained in regions with high insecurity; in these
areas, political stabilization, localized deployment of health resources, increased administrative
integration and national capacity are required to mitigate incidence. Conflict-related variables
should be explicitly integrated into risk mapping and prioritization of targeted sleeping sickness
research and mitigation initiatives.
Background
Sleeping sickness re-emerged in Uganda in the 1970s, and
continues to pose a public health and economic burden
[1-3]. Similar re-emergence has been reported across sub-
Saharan Africa since the 1970s, including outbreaks in the
Democratic Republic of the Congo (DRC), Sudan [4], and
Angola [5]. In many cases, sleeping sickness outbreaks
have coincided with periods of civil conflict and instabil-
ity in affected countries and regions. Conflict in this con-
text refers to the occurrence of civil war, rebel insurgency,
violent governance, political or military oppression of
populations, and military combat. These temporal associ-
ations are not purely spurious; patterns and processes
related to conflict have been identified as determinants of
sleeping sickness incidence and outbreaks [4,5]. An
improved understanding of the specific processes linking
conflict to sleeping sickness incidence can guide geo-
graphical predictions of disease risk and optimization of
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intervention resources. This paper provides a review and
characterization of the processes by which conflict has
contributed to the occurrence of sleeping sickness out-
breaks across sub-Saharan Africa, with a focus on south-
eastern Uganda (Figure 1).
Sleeping sickness: epidemiology, geographical 
distribution, and re-emergence
Sleeping sickness is the name used to describe the human
form of African trypanosomiasis (Trypanosoma spp.), a pro-
tozoan parasitic disease affecting humans, livestock, and a
large number of sylvatic species in much of sub-Saharan
Africa (Figure 1). Transmitted by the tsetse fly vector
(Glossina spp.), trypanosomiasis represents an important
public health and economic burden in sub-Saharan Africa
[6-8]. Sleeping sickness is characterized by highly variable
and non-specific symptoms in its early stages [9], which
are often mis-diagnosed as malaria [10]. Late stage sleep-
ing sickness includes body weakness, progressive emacia-
tion, slurred speech, mental confusion, and coma leading
to death in all untreated cases [9]. There are two sub-spe-
cies of human-infectious trypanosomes, including T. b.
gambiense, which causes a more chronic disease, and is
dominant in Western Africa, and T. b. rhodesiense, which
causes more acute disease, and is generally found in East
and Southern Africa, east of the Rift Valley [11]. The two
forms of disease have different ecology, pathology, and
epidemiology. T. b. rhodesiense progresses from early non-
specific symptoms to infection of the central nervous sys-
tem and death within months, while T. b gambiense typi-
cally follows a chronic clinical course progressing over
several years.
Sleeping sickness treatment is expensive, complicated,
and can be dangerous for the patient [12]. Current drugs
are in scarce or uncertain supply, and there is limited opti-
mism with respect to forthcoming drugs entering the mar-
ket, particularly for the treatment of late-stage T. b.
rhodesiense [12-17]. The dominant treatment for late-stage
sleeping sickness that involves the central nervous system
is melarsoprol, an organoarsenic compound with high
toxicity and varying rates of treatment failure [12,18].
Active surveillance and case treatment have been found to
be extremely effective in reducing disease transmission,
particularly for T. b. gambiense [12,18], which is generally
confined to a human-fly-human cycle [19]. T. b. rhode-
siense transmission to humans is influenced by prevalence
of the parasite in the animal reservoir; in east Africa, live-
stock represent an important reservoir for disease, and
control of livestock infection and tsetse populations are
important for reducing transmission to humans [12,19].
Sleeping sickness was first identified and characterized in
Africa in the last few years of the 19th century, a period that
coincided with widespread and severe epidemics of the
disease in Kenya, Tanzania, Uganda, Nigeria, and the
Democratic Republic of the Congo (DRC). These epidem-
ics have been associated with social and environmental
disruptions during colonial administration [11,20], as
well as livestock restocking following an 1889–1892 rind-
erpest epidemic [21]. The disease was generally brought
under control by the 1960s in much of Africa but has re-
emerged in many countries since the 1970s [8]. The re-
emergence has been attributed to post-independence
political turbulence, unstable governments, limited pub-
lic health resources, and re-allocation of domestic and
international funding towards malaria, HIV/AIDs, and
tuberculosis.
In Uganda, a large epidemic of T. b. rhodesiense began in
1976 in the south-east of the country (Figure 1). Between
1976 and the decline of the epidemic in the mid-1990s,
over 40,000 cases were reported in this region. Given esti-
mates of significant under-reporting due to passive sur-
veillance and diagnostic difficulties, the actual number of
cases may have been ten times higher, with all unreported
and untreated cases assumed to be fatal [3,22,23]. Though
incidence declined in the 1990s, the disease continues to
spread into new regions. Recent research suggests that cen-
tral Ugandan districts may be at particularly high risk of
infection and increased incidence [24]. These reports are
particularly pertinent given that Uganda represents the
boundary between the ranges of the two sub-species of
sleeping sickness. While T. b. rhodesiense continues to
spread from its traditional focus in the south and east,
cases of T. b. gambiense continue to be recorded in north-
western Uganda in the West Nile Region. These foci are
currently separated by fewer than 200 kilometers, much of
which is inhabited by tsetse flies. The two diseases differ
widely in their treatment and control: it is very difficult to
distinguish the two sub-species clinically [25]; a seriolog-
ical card agglutination test (CATT) is commonly used for
T. b. gambiense diagnosis, but is inappropriate for T. b.
rhodesience – the test would not be effective in the presence
of both diseases [26]; drug treatment regimes, which are
expensive and can be dangerous, differ depending on the
sub-species of infection [26]; approaches to control, such
as focus on vector eradication, livestock treatment, or
active livestock or human surveillance, will be more or
less appropriate based on sub-species [25,26]; there may
be potential for exchange of genetic material and
increased drug resistance where the sub-species overlap
[26,27]; cost-effective and successful control of sleeping
sickness would become extremely difficult to achieve
where both species were present. The potential for overlap
of the two disease foci is therefore a considerable eco-
nomic and public health concern [2].
Similar re-emergent outbreaks and incidence have been
recorded in other countries (Figure 1). Angola experi-Conflict and Health 2007, 1:6 http://www.conflictandhealth.com/content/1/1/6
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enced outbreaks in the late 1800s and early 1900s. By
1974, the year before Angola's independence, however,
only three new cases of sleeping sickness were recorded
[5]. Sleeping sickness re-emerged in Angola during a pro-
longed civil war following the country's independence in
1975 [19]. Although a peace agreement was signed in
2002, Angola's infrastructure and political situation
remain highly unstable; the country is classified as 'epi-
demic' for sleeping sickness by the World Health Organi-
zation (WHO), along with the Democratic Republic of the
Congo (DRC) and southern Sudan [28]. In Sudan, disease
resurgence in the late 1970s was largely controlled by a
Belgian-Sudanese trypanosomiasis treatment and control
initiative [18]. Civil war in the 1980s and 1990s, however,
lead to collapse of the control programme, and by 1997,
sleeping sickness had re-emerged in Sudan with preva-
lence rates as high as 19% in south-western communities
bordering the Democratic Republic of the Congo [18]. Re-
emergence of disease and new epidemics were reported in
the DRC in the 1970s and 1980s [29]. The DRC continues
to experience Africa's highest burden of disease from
sleeping sickness; in 1994, 72% prevalence was reported
in one village, Kimbanzi [19]. The DRC represents an
important source of infection for neighbouring countries.
According to the WHO [28], Angola and southern Sudan
have also reported high prevalences: between 20% and
50% in some communities. In several areas, sleeping sick-
ness is the first or second greatest cause of mortality,
ahead of HIV/AIDS [19]. Currently, the DRC, Angola, and
Sudan remain the countries most affected by sleeping
sickness.
Countries considered to be 'highly endemic', with sleep-
ing sickness re-emergence and expected incidence increase
include Cameroon, Uganda, Central African Republic,
Chad, Congo, Côte d'Ivoire, Guinea, Mozambique, and
Tanzania [28]. Incidence and prevalence are highly focal.
In the Central African Republic, for example, villages bor-
dering Sudan have reported epidemic levels of disease
[18]. Sporadic or low endemic levels of sleeping sickness
have been reported in Benin, Burkina Faso, Equatorial
Guinea, Gabon, Kenya, Mali, Togo and Zambia. Unre-
ported foci are likely to exist in additional countries,
including Africa's most populated nation, Nigeria [30].
While few sleeping sickness cases have been reported in
Kenya since the late 1960s and early 1970s, cattle infec-
tion remains an economic burden and there is ongoing
incidence of disease across the border in south-eastern
Uganda.
Conflict, infectious disease, and sleeping sickness
Conflict and war have long been recognized as determi-
nants of infectious disease risk [31,32]. Increased travel,
trade, and inter-regional conflict have played a key role in
Distribution of sleeping sickness in Africa and map of Uganda showing the case study area Figure 1
Distribution of sleeping sickness in Africa and map of Uganda showing the case study area. The approximate loca-
tion of the 'Luwero Triangle' is shown; this is where much of the conflict and violence was concentrated during Uganda's civil 
war (1979–86). Sleeping sickness status data from WHO (2001).Conflict and Health 2007, 1:6 http://www.conflictandhealth.com/content/1/1/6
Page 4 of 10
(page number not for citation purposes)
the introduction and spread of diseases between civilisa-
tions and continents [33-35]. The influenza pandemic
precipitated by World War I is a well-recognized example
of a disease epidemic emerging from conflict conditions;
deaths due to influenza exceeded deaths in battle [36].
Recent research in the Democratic Republic of the Congo
(DRC) found that elevated mortality during the recent
civil war was closely associated with violence and that
most deaths were due to malnutrition or infectious dis-
ease [37]. On-going armed conflict has hampered the
international polio eradication campaign, particularly in
Somalia and Afghanistan, areas of persistent polio infec-
tion and high insecurity [38,39]. Outbreaks and increased
disease incidence have been attributed to a range of fac-
tors associated with conflict [40], including decreased
hygiene, dietary deficiencies, decline of health services,
travel insecurity, reduced access of humanitarian support,
reduced veterinary and zoonoses control, and internal dis-
placement of populations into marginal areas. The associ-
ations between conflict and infectious disease are
particularly prevalent in Africa, where there remain many
foci of ongoing civil conflict, and where infectious dis-
eases remain important contributors to national mortality
[41-43].
The sensitivity of sleeping sickness incidence to conflict-
related processes is associated with the low transmission
potential of the disease. A general model of the disease
was developed by Rogers [44]. While developed for ani-
mal trypanosomiasis, an adapted and simplified equation
can provide useful insights into the parameters affected
the transmission potential of sleeping sickness; here we
adapt the model for one tsetse species, one trypanosome
species, and one host species – in this case we are inter-
ested in human disease, but animals are also important
reservoirs of infection, particularly in the case of T. b.
rhodesiense. The reproductive rate (R0) can be estimated
using the following general equation [44-46]:
R0 = α2mbce-uT/ur   (Eq. 1)
Where:
R0 Basic reproductive ratio
α Daily biting rate of flies on humans (or animal reser-
voirs)
m Ratio of tsetse flies to humans (or animals)
b Probability of a fly becoming infected from an infected
person (or animal)
c Probability of a person (or animal) becoming infected
from an infected fly
1/u Life expectancy of tsetse flies (days)
T Incubation period in tsetse flies (days)
1/r Duration of infection in a person (or animal) (days)
R0 reflects the number of additional cases that a single case
is expected to generate and therefore represents the trans-
mission potential of a pathogen; transmission will occur
and epidemics can result when R0 > 1. The values of the
parameters vary based on the species of host, parasite and
vector of interest, as well as the context of the area and sit-
uation. In this case, we assume that the values of b, c, and
T are constant and unrelated to political or social events.
The remaining parameters, m, α, 1/u, and 1/r, however,
could vary due to external influences.
In humans, the R0 value is generally below one and trans-
mission cannot sustain itself; T. b. rhodesiense is mainly a
zoonosis, with disease occurring commonly in cattle pop-
ulations. In humans, periods of relatively low-level or
undetected disease are punctuated by periods of severe
outbreak [27]. Sleeping sickness, particularly T. b. rhode-
siense, is characterized by the occurrence of distinct epi-
demics whose temporal occurrence has been consistently
observed to parallel or lag periods of conflict in affected
areas [24,47]. This epidemic pattern is a function of the
low transmission potential of sleeping sickness compared
to other infectious diseases; one case of sleeping sickness
will be likely to result in further cases only under particu-
lar circumstances strongly favouring transmission [8].
Transmission can be enhanced by increasing the equation
parameters (Eq. 1) [8]; when sufficiently strong or pro-
longed, an outbreak is triggered. Conflict-related proc-
esses, therefore, can influence sleeping sickness incidence
by affecting the parameters in the model (m, α, 1/u, or 1/
r); these can include a range of ecological, social, and bio-
physical determinants [1]. Impacts on the biting rate of
flies (α), such as increased exposure of people to infested
areas, will be particularly important as this parameter
exponentially affects the value of R0. Similarly, conditions
affecting the lifespan of the fly (1/u), such as vector con-
trol measures, will be important as this parameter appears
twice in the equation.
The case of south-eastern Uganda
Figure 2 shows a time-line of sleeping sickness incidence
in south-eastern Uganda between 1900 and 2000. As seen
in this figure, the epidemic of 1900–1920 coincides with
establishment of colonial rule in Uganda, while the
1940–1946 epidemic coincides with World War II. There
has been extensive discussion of the role of colonial gov-
ernance in the 1900–1920 sleeping sickness outbreak
[11,21,27,48-51]. The more recent T. b. rhodesiense epi-
demic in 1976–1990s coincided with political instabilityConflict and Health 2007, 1:6 http://www.conflictandhealth.com/content/1/1/6
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and civil war during and after the rule of Idi Amin [24].
Uganda's civil war influenced the transmission potential
of sleeping sickness in a number of ways, including:
breakdown of veterinary and public health services (↑1/r)
[52-54]; collapse of vector control (↑m, ↑1/u); regrowth of
bushy tsetse habitat in abandoned agricultural fields (↑m)
[19,52]; increasing displacement of human and animal
populations into marginal or swampy areas where they
are more likely to be bitten by flies (↑α) [52]; In Uganda,
internally displaced people (IDP) fled areas of intense
conflict, particularly in the 'Luwero Triangle' region (Fig-
ure 1), an area in south-central Uganda where much of the
conflict and violence was concentrated [55,56]. Refugees
and IDPs returning home after the conflict faced increased
risk due to the vegetation and new tsetse habitat that had
grown during their absence (↑m,  ↑α). These processes
directly affected a number of parameters in the sleeping
sickness transmission model (m, α, 1/u, 1/r), increasing
the transmission potential of the disease (R0). The R0
value increased via these processes over several years
(resulting in a time lag between the peak in civil conflict
and the outbreak peak) before exceeding the threshold
required for an outbreak.
Conflict and sleeping sickness in sub-Saharan 
Africa
The trends and processes contributing to south-eastern
Uganda's sleeping sickness epidemic have also been
observed in other countries. Despite the epidemiological
differences between T. b. rhodesiense and T. b. gambiense,
the temporal occurrence of outbreaks or high incidence of
both sub-species are associated with times of conflict. An
association between land cover change and sleeping sick-
ness similar to the process observed in south-eastern
Uganda has been suggested in Kenya; increased vegetation
growth around homesteads and the resulting movement
of tsetse flies into peridomestic environments likely con-
tributed to the sleeping sickness outbreaks in Kenya in
1965 [57]. Outbreaks in the 1990s in Sudan, as in south-
eastern Uganda, have been linked to abandonment of
land, bush invasion, and increased risk of exposure for
returning IDPs [52]. In north-western Uganda in the West
Nile region, T. b. gambiense infection is believed to have
been introduced to the area by refugees returning from
infected areas of Sudan following Uganda's civil war [58].
Collapse of essential health services, and veterinary and
vector control contribute consistently to increased disease
risk through impacts on the transmission parameters of
sleeping sickness (m, 1/r, and 1/u). Reduced surveillance
and treatment directly affect the duration of infection in
both humans and animal reservoirs of infection (↑1/r),
while reduction of health and veterinary services increase
the duration of infection in people and infected animals
(↑1/r). Collapse of vector control can affected both tsetse
numbers (↑m) and the average lifespan of flies in the area
(↑1/u). Surveillance and treatment are particularly impor-
tant for the mitigation and control of T. b. gambiense. In
Sudan, for example, absence of active case finding was a
major factor contributing to the resurgence of sleeping
sickness in the 1990s [18]. Sudanese health and disease
control infrastructure was essentially non-operable during
two decades of civil war in the 1970s-1990s [19]. In the
DRC, negligible staff salaries, lack of motivation, poor
road conditions, petrol shortages, and corruption were
identified as key constraints to the efficacy of mobile sur-
veillance teams, which failed to contain sleeping sickness
incidence in the 1990s [19]. Limited or absent veterinary
and vector control programs can be more important in T.
b. rhodesiense areas, where livestock reservoirs can have
considerable influence on transmission potential [21,59].
Insecurity due to conflict further constrains the capacity of
both national governments and external organizations to
respond to outbreak situations. In Angola, for example,
peripheral mining regions were subject to active insurgen-
cies, resulting in high insecurity; this made implementa-
tion of sleeping sickness control activities logistically
impossible [60]. Collapse of training schools for health
care workers, nurses and laboratory technicians contrib-
ute to further decline in sleeping sickness control initia-
tives (↑ 1/r). Abel et al. [60] note that in the 1990s, at least
two Angolan diagnostic and treatment centres had to be
abandoned due to rebel attacks.
In many war-zone outbreaks, non-governmental organi-
zations (NGO) and United Nations (UN) agencies
assume partial or full responsibility for outbreak response
[5,18]. In Angola in the 1990s, for example, religious
organizations played an important role in intervention
activities when high insecurity in the country limited UN
and international NGO intervention in remote areas [60].
While external humanitarian support may contribute
essential services, lack of harmonization and integration
of activities between organizations is a constraint to con-
sistent and continuous sleeping sickness control during
conflict [18,19]. In some cases, resurgence of sleeping
sickness during periods of conflict has occurred in previ-
ous disease hot spots, as in the case of Sudan [18]; in oth-
ers, resurgence is occurring outside of traditional disease
foci, as is currently occurring in sleeping sickness spread
into central Uganda [24].
The range of specific processes by which conflict has con-
tributed to sleeping sickness risk is summarized in Table
1. This summary identifies the dominant impacts and vul-
nerabilities associated with conflict, their effects on the
transmission determinants of sleeping sickness, and the
resulting impact on the R0 equation parameters of sleep-
ing sickness. Four key impact categories are identified,
including: 1) Economic and global effects, 2) Decline ofConflict and Health 2007, 1:6 http://www.conflictandhealth.com/content/1/1/6
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health systems and services, 3) Forced migration and
internal displacement of populations, and 4) Regional
insecurity and restricted access for external humanitarian
support.
The proportionate importance of the factors summarized
in Table 1 will differ between rhodesiense and gambiense
affected areas. Transmission during g ambiense outbreaks
is usually dominated by a human-fly-human cycle.
Reduced treatment of humans and decline of health sys-
tems will therefore have greater impact in gambiense
affected regions. In these areas, decline of health services
leads to increased duration of human infection (↑1/r in
humans). Changes in livestock infection will have greater
impact in rhodesiense affected regions. In these areas, civil
war leads to reduced cattle treatment, thus increasing the
duration of cattle infection (↑1/r in cattle) and the reser-
voir of human-infectious parasites for transmission to the
human population. In both gambiense  and  rhodesiense
affected regions, reduced tsetse control increases vector
populations (↑m, ↑1/u). Displacement of people and ani-
mals into marginal, bushy or swampy areas further pro-
motes increased human, fly, and cattle contact (↑a).
Discussion
Conflict is a major determinant of sleeping sickness out-
breaks in sub-Saharan Africa. Efforts to prevent and con-
trol sleeping sickness must identify and integrate
knowledge of the processes by which conflict affects dis-
ease risk. Prioritization of high-risk areas and targeted
intervention can be optimized by consideration of con-
flict in sleeping sickness-affected countries. Sleeping sick-
ness intervention in Africa is constrained by a range of
factors and processes. Increased drug development is
needed to identify and develop newer, safer drugs with
more secure availability and supply to the African market.
The epidemic nature of sleeping sickness means that when
cases decline, resources are often rapidly reallocated to
other health priorities until the occurrence of another out-
break. Consistent and active surveillance is difficult to
rationalize during inter-outbreak periods in affected
countries where resources are strained. Since late-stage
sleeping sickness cases are expensive and difficult to treat,
however, active surveillance, early treatment, and out-
break prevention can considerably reduce the burden of
disease. In countries recovering from recent civil war,
rapid re-establishment of essential health services and
Sleeping sickness epidemics and major political events in Uganda, 1905–2000 Figure 2
Sleeping sickness epidemics and major political events in Uganda, 1905–2000. Cases from 1936 onwards include 
south-eastern Uganda only. Sources: Sleeping sickness data 1905–36 deaths [62], 1925–36 cases [62], 1937–58 cases [63], 
1960–71 cases (Unpublished report, 1992, Mbulamberi, D. B. The sleeping sickness situation in Uganda: past and present. 
National Sleeping Sickness Control Program, Jinja, Uganda), 1972–75 cases [54], and 1976–2001 cases (Ministry of Health, 
Uganda); Political time-series [56, 64, 65].Conflict and Health 2007, 1:6 http://www.conflictandhealth.com/content/1/1/6
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active surveillance and treatment will be central to reduc-
ing sleeping sickness incidence. The focal nature of sleep-
ing sickness means that resources can be optimized in the
short term by targeting outbreak locations and areas bor-
dering countries with high incidence. In cases such as
Uganda, where conflict is intermittent and regional, inter-
vention is not extensively constrained by insecurity. Mobi-
lization of national and international resources to support
intervention in central Uganda is logistically feasible. As
noted by Fèvre et al. [2], T. b. rhodesiense is theoretically
not difficult to prevent, but can be challenging to control
once established. In the case of T. b. rhodesiense in Uganda,
surveillance and control of livestock infection/move-
ments can contribute to a decrease in both the animal res-
ervoir of infection and spread of the parasite to new
populations. Much of this support will need to be targeted
at policy and infrastructure development. Central Uganda
is currently experiencing spread of disease and establish-
ment of new T. b. rhodesiense foci; rapid intervention to
curb these developments is needed to prevent increased
burden of disease due to sleeping sickness in Uganda.
Conflict has played an important role in contributing to
the incidence and distribution of sleeping sickness in sub-
Saharan Africa. Regrettably, the causes of sleeping sickness
are also the main constraints to eradication initiatives:
"virtually by definition, [sleeping sickness] is a public
health problem in places where a research infrastructure
can hardly exist" [[60] p. 147]. The campaign to eliminate
the tsetse vector from the African continent [12,14,61]
will face enormous constraints due to continued conflict.
Absence of appropriate administrative infrastructures for
Table 1: Impacts of social conflict on sleeping sickness in sub-Saharan Africa
Impacts and vulnerabilities associated with conflict Impact on transmission determinants Parameter impact
Economic and global effects
• Reliance of governments on external funding for control resources and 
donor reluctance due to political insecurity
Reduction in provision of public health services ↑ 1/r in people
• Reduced reliability of economy for international investment and aid
• Collapse of businesses and local economies. Loss of employment, 
income &provision of products & services
Decreased treatment and control of animal infection and transmission ↑ 1/r in animal reservoirs
• Abandonment or appropriation of land; changes in land ownership and 
land use. Possible increased vector habitat
• Loss of educated and business elite in cases of emigration, exile, or 
purging; decreased overall response capacity and economic stability
Decreased vector control ↑ 1/u, ↑m
Decline of health systems and services
• Absence of public health funding due to economic collapse, corruption, 
or re-allocation of funds to security or military expenses
Reduction in provision of public health services ↑ 1/r in people
• Collapse or decline in training programs for public health, veterinary, 
and vector control workers; decline in personnel and expertise; limited 
surge capacity for outbreak response
Decreased treatment and control of animal infection and transmission ↑ 1/r in animal reservoirs
• Total absence of case surveillance or reporting in some rebel-
controlled areas or high-conflict zones; limited screening/treatment
• Demotivation of health care, veterinary and vector control personnel 
caused by insecurity, inflation, or no pay
Decreased vector control ↑ 1/u, ↑m
• Collapse of vector control and veterinary health programs
Forced migration and internal displacement of populations
• Increased mortality and morbidity due to conflict violence Increased exposure of people and cattle to tsetse habitat ↑ a
• Transport of people and animal hosts, vectors, and parasites into 
potentially naïve or uninfected populations
• Loss of livelihoods – increased stress, reduced household resources, 
reduced health &nutritional status
Increased vector habitat ↑m
• Decreased access to health facilities; decreased population health Increased mortality -
• Separation of household units
• Abandonment of land; vegetation re-growth; increased vector habitat
Regional insecurity and restricted access for external 
humanitarian support
•Treatment facilities prone to looting and insurgent attacks Reduction in provision of public health services ↑ 1/r in people
• Insecurity in affected regions constrains or prevents control and 
implementation logistics; access of mobile teams limited
Increased mortality -
• Lack of integration and continuity in primary care where a range of 
NGOs are the dominant providers of health and intervention services.
• Patients delay seeking medical help due to travel insecurity or 
unavailable transport; higher proportion of late-stage or unreported and 
untreated cases.Conflict and Health 2007, 1:6 http://www.conflictandhealth.com/content/1/1/6
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program implementation in affected countries represents
the most acute challenge to such campaigns; this is true
even for countries such as Uganda where conflict is only
intermittent or regional. In Uganda, administrative capac-
ity and intersectoral cooperation are important con-
straints to coordination of intervention activities [2].
While top-down, continent-wide eradication campaigns
are ambitious and appealingly goal-oriented, progress to
curb sleeping sickness is more likely to come from slow
development of national capacity, policy infrastructure,
administrative integration and political stabilization in
affected countries. In many cases, insecurity due to con-
flict has constrained international or external intervention
and control. Local interventions, with localized infrastruc-
ture and rural deployment capacity, may be better placed
to provide essential services during times of intense or
widespread conflict. Donors and aid agencies should con-
tinue to support national, regional, and community miti-
gation and intervention initiatives towards the common
goal of reducing and eliminating sleeping sickness bur-
den.
Prioritization of high-risk areas for sleeping sickness and
trypanosomiasis control should explicitly integrate the
occurrence of conflict and its impacts on transmission
risk. The occurrence of conflict and presence of large
number of internally displaced people can be integrated
into current risk maps in addition to land cover, tsetse
habitat, and livestock distributions. An understanding of
areas where conflict may contribute to increased disease
risk can guide prioritization of continent-wide as well as
national mitigation programs.
Conclusion
Conflict is an important determinant of sleeping sickness
outbreaks in sub-Saharan Africa. In Uganda, the two sub-
species of sleeping sickness can be expected to merge in
the absence of immediate and targeted intervention in
central districts; the presence of both diseases in one
region will dramatically increase burden of disease as well
as the complexity and difficultly of subsequent control
initiatives. Control and prevention of sleeping sickness by
national and international authorities should explicitly
integrate consideration of conflict and its impacts into
mapping and targeting of regions for priority interven-
tion. Prevention and control campaigns should be
assessed and evaluated against the ability of the initiative
to address, mitigate, or alleviate the conflict-related driv-
ers of disease risk. The occurrence of sleeping sickness in
conflict-affected areas will severely constrain the success
and cost-benefit evaluations of continent-wide tsetse
eradication campaigns. Prevention of sleeping sickness
risk in affected sub-Saharan African countries requires
increased international focus on development of adminis-
trative policy, capacity, integration, and infrastructure to
implement localized control strategies.
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